Robotic adrenalectomy: comparison of DaVinci, HUGO™-RAS and Versius® platforms-a preliminary retrospective analysis
- PMID: 40965751
- DOI: 10.1007/s13304-025-02414-8
Robotic adrenalectomy: comparison of DaVinci, HUGO™-RAS and Versius® platforms-a preliminary retrospective analysis
Abstract
Robot-assisted adrenalectomy (RAA) has emerged as an advantageous approach in challenging cases and suspicious lesions, although high costs represent the main drawback to its broader application. Besides Da-Vinci, new platforms have been recently launched on the market and need to be validated in clinical practice. DaVinci, HUGO™-RAS and Versius® platforms were introduced in our center in 2012, 2022, and 2024, respectively. We aimed to compare the perioperative outcomes of these robotic platforms. Among 730 adrenalectomies (2012-2024), 149 (20.4%) RAAs were performed. All procedures performed by means of HUGO™-RAS and Versius® platforms were compared with similar procedures (in terms of patient's and lesion's features) performed with the DaVinci technology in the same period (2022-2024). Ten patients were included in each group. Patients' and lesions' features were similar. Median BMI and lesions' size were 27.9, 24.9, and 26.1 kg/m2 and 42.5, 42.5, and 32.5 mm in DaVinci, HUGO™-RAS, and Versius® groups, respectively (p = 0.360, p = 0.236). The groups were comparable for docking time, console time, and operative time (5 vs. 5 vs. 7 min, p = 0.059, 58.5 vs. 58 vs. 39 min, p = 0.393, 109.5 vs. 110.5 vs. 104.1 min, p = 0.668, respectively). No conversion or perioperative complications were registered. Postoperative hospital stays were similar (2 days in all groups, p = 0.629). RAA, whatever platform is used, confirmed to be a safe and effective approach, potentially expanding indications for minimally invasive adrenalectomy. Even though new platforms have been applied in less demanding cases in our learning curve phase, the introduction of new different platforms may lead to a costs reduction, thus to a broader diffusion of RAA.
Keywords: DaVinci; HUGO™-RAS; Operative time; Postoperative complications; Robotic adrenalectomy; Versius®.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: Marco Raffaelli has a consultant agreement with Medtronic, AB Medica, and Intuitive Surgical. Priscilla Francesca Procopio, Francesco Pennestrì, and Antonio Laurino have a consultant agreement with Medtronic. Carmela De Crea and Annamaria Martullo declare no conflicts of interest. Compliance with ethical standards: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Research involving human participants and/or animals: This article does not contain any studies with animals performed by any of the authors. Informed consent: Informed consent was obtained from all individual participants for whom identifying information is included in this article.
References
-
- Thompson LH, Nordenström E, Almquist M et al (2016) Risk factors for complications after adrenalectomy: results from a comprehensive national database. Langenbecks Arch Surg 402:315. https://doi.org/10.1007/S00423-016-1535-8 - DOI - PubMed - PMC
-
- Elfenbein DM, Scarborough JE, Speicher PJ, Scheri RP (2013) Comparison of laparoscopic versus open adrenalectomy: results from American College of Surgeons-National Surgery Quality Improvement Project. J Surg Res 184:216–220. https://doi.org/10.1016/J.JSS.2013.04.014 - DOI - PubMed
-
- Wang HS, Li CC, Chou YH et al (2009) Comparison of laparoscopic adrenalectomy with open surgery for adrenal tumors. Kaohsiung J Med Sci 25:438–444. https://doi.org/10.1016/S1607-551X(09)70539-X - DOI - PubMed - PMC
-
- Laparoscopic adrenalectomy with the aid of the AESOP 2000 robot—PubMed. https://pubmed.ncbi.nlm.nih.gov/10427347/ . Accessed 20 Mar 2025
-
- Hyams ES, Stifelman MD (2009) The role of robotics for adrenal pathology. Curr Opin Urol 19:89–96. https://doi.org/10.1097/MOU.0B013E32831B446C - DOI - PubMed
LinkOut - more resources
Full Text Sources
